Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair

Bitget2026/09/23 12:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors.
Freda-Smith will serve as chair of the board’s audit committee.
She most recently served as chief audit and risk officer at Ralph Lauren.
Earlier roles include managing director at Deloitte & Touche, advising Fortune 500 clients on SEC reporting, capital markets deals, U.S. GAAP, IFRS.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609230800PRIMZONEFULLFEED9832050) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair

You may also like

Crypto prices